Skip to main content
Erschienen in: Current Allergy and Asthma Reports 9/2019

01.09.2019 | Autoimmunity (TK Tarrant, Section Editor)

Genetic and Environmental Contributors for Celiac Disease

verfasst von: Gloria Serena, Rosiane Lima, Alessio Fasano

Erschienen in: Current Allergy and Asthma Reports | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Celiac disease (CD) is an autoimmune enteropathy triggered by gluten. The purpose of this review is to examine the major genetic and environmental factors that contribute to CD pathogenesis.

Recent Findings

We reviewed the current state of knowledge on the genetic and environmental components that play a role in CD onset. A genome-wide association study (GWAS) analysis has highlighted several genes other than HLA involved in CD. Recent studies have shown that HLA haplotype influences the microbiome composition in infants and that dysbiosis in the intestinal microflora, in turn, contributes to loss of tolerance to gluten. Recently, observational studies have discussed the hypothesis stating that breast-feeding had a protective role against CD onset.

Summary

CD etiology is influenced by genetic and environmental factors. A better understanding of these components would deepen our knowledge on the mechanisms that lead to loss of tolerance and could help in developing a more “personalized medicine.”
Literatur
1.
Zurück zum Zitat Serena G, Camhi S, Sturgeon C, Yan S, Fasano A. The role of gluten in celiac disease and type 1 diabetes. Nutrients. 2015;7(9):7143–62.PubMedPubMedCentral Serena G, Camhi S, Sturgeon C, Yan S, Fasano A. The role of gluten in celiac disease and type 1 diabetes. Nutrients. 2015;7(9):7143–62.PubMedPubMedCentral
2.
Zurück zum Zitat Thomas KE, Sapone A, Fasano A, Vogel SN. Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in celiac disease. J Immunol. 2006;176(4):2512–21.PubMed Thomas KE, Sapone A, Fasano A, Vogel SN. Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in celiac disease. J Immunol. 2006;176(4):2512–21.PubMed
3.
Zurück zum Zitat Fukunaga M, Ishimura N, Fukuyama C, Izumi D, Ishikawa N, Araki A, et al. Celiac disease in non-clinical populations of Japan. J Gastroenterol. 2018;53(2):208–14.PubMed Fukunaga M, Ishimura N, Fukuyama C, Izumi D, Ishikawa N, Araki A, et al. Celiac disease in non-clinical populations of Japan. J Gastroenterol. 2018;53(2):208–14.PubMed
4.
Zurück zum Zitat Balakireva AV, Zamyatnin AA. Properties of gluten intolerance: gluten structure, evolution, pathogenicity and detoxification capabilities. Nutrients. 2016;8(10).PubMedCentral Balakireva AV, Zamyatnin AA. Properties of gluten intolerance: gluten structure, evolution, pathogenicity and detoxification capabilities. Nutrients. 2016;8(10).PubMedCentral
5.
Zurück zum Zitat Skovbjerg H, Hansen GH, Niels-Christiansen LL, Anthonsen D, Ascher H, Midhagen G, et al. Intestinal tissue transglutaminase in coeliac disease of children and adults: ultrastructural localization and variation in expression. Scand J Gastroenterol. 2004;39(12):1219–27.PubMed Skovbjerg H, Hansen GH, Niels-Christiansen LL, Anthonsen D, Ascher H, Midhagen G, et al. Intestinal tissue transglutaminase in coeliac disease of children and adults: ultrastructural localization and variation in expression. Scand J Gastroenterol. 2004;39(12):1219–27.PubMed
6.
Zurück zum Zitat Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163(3):286–92.PubMed Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163(3):286–92.PubMed
7.
Zurück zum Zitat Dieli-Crimi R, Cenit MC, Nunez C. The genetics of celiac disease: a comprehensive review of clinical implications. J Autoimmun. 2015;64:26–41.PubMed Dieli-Crimi R, Cenit MC, Nunez C. The genetics of celiac disease: a comprehensive review of clinical implications. J Autoimmun. 2015;64:26–41.PubMed
8.
Zurück zum Zitat Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391(10115):70–81.PubMed Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391(10115):70–81.PubMed
9.
Zurück zum Zitat Kelly CP, Bai JC, Liu E, Leffler DA. Advances in diagnosis and management of celiac disease. Gastroenterology. 2015;148(6):1175–86.PubMed Kelly CP, Bai JC, Liu E, Leffler DA. Advances in diagnosis and management of celiac disease. Gastroenterology. 2015;148(6):1175–86.PubMed
10.
Zurück zum Zitat Borghini R, Donato G, Marino M, Casale R, Tola MD, Picarelli A. In extremis diagnosis of celiac disease and concomitant wheat allergy. Turk J Gastroenterol. 2018;29(4):515–7.PubMedPubMedCentral Borghini R, Donato G, Marino M, Casale R, Tola MD, Picarelli A. In extremis diagnosis of celiac disease and concomitant wheat allergy. Turk J Gastroenterol. 2018;29(4):515–7.PubMedPubMedCentral
11.
Zurück zum Zitat Murad H, Jazairi B, Khansaa I, Olabi D, Khouri L. HLA-DQ2 and -DQ8 genotype frequency in Syrian celiac disease children: HLA-DQ relative risks evaluation. BMC Gastroenterol. 2018;18(1):70.PubMedPubMedCentral Murad H, Jazairi B, Khansaa I, Olabi D, Khouri L. HLA-DQ2 and -DQ8 genotype frequency in Syrian celiac disease children: HLA-DQ relative risks evaluation. BMC Gastroenterol. 2018;18(1):70.PubMedPubMedCentral
12.
Zurück zum Zitat Fasano A, Catassi C. Clinical practice. Celiac disease. N Engl J Med. 2012;367(25):2419–26.PubMed Fasano A, Catassi C. Clinical practice. Celiac disease. N Engl J Med. 2012;367(25):2419–26.PubMed
13.
Zurück zum Zitat Garrote JA, Gomez-Gonzalez E, Bernardo D, Arranz E, Chirdo F. Celiac disease pathogenesis: the proinflammatory cytokine network. J Pediatr Gastroenterol Nutr. 2008;47(Suppl 1):S27–32.PubMed Garrote JA, Gomez-Gonzalez E, Bernardo D, Arranz E, Chirdo F. Celiac disease pathogenesis: the proinflammatory cytokine network. J Pediatr Gastroenterol Nutr. 2008;47(Suppl 1):S27–32.PubMed
14.
Zurück zum Zitat Kim SM, Mayassi T, Jabri B. Innate immunity: actuating the gears of celiac disease pathogenesis. Best Pract Res Clin Gastroenterol. 2015;29(3):425–35.PubMedPubMedCentral Kim SM, Mayassi T, Jabri B. Innate immunity: actuating the gears of celiac disease pathogenesis. Best Pract Res Clin Gastroenterol. 2015;29(3):425–35.PubMedPubMedCentral
15.
Zurück zum Zitat Lammers KM, Chieppa M, Liu L, Liu S, Omatsu T, Janka-Junttila M, et al. Gliadin induces neutrophil migration via engagement of the formyl peptide receptor, FPR1. PLoS One. 2015;10(9):e0138338.PubMedPubMedCentral Lammers KM, Chieppa M, Liu L, Liu S, Omatsu T, Janka-Junttila M, et al. Gliadin induces neutrophil migration via engagement of the formyl peptide receptor, FPR1. PLoS One. 2015;10(9):e0138338.PubMedPubMedCentral
16.
Zurück zum Zitat Lammers KM, Lu R, Brownley J, Lu B, Gerard C, Thomas K, et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology. 2008;135(1):194–204.e3.PubMed Lammers KM, Lu R, Brownley J, Lu B, Gerard C, Thomas K, et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology. 2008;135(1):194–204.e3.PubMed
17.
Zurück zum Zitat Lebwohl B, Green PHR. New developments in celiac disease. Gastroenterol Clin N Am. 2019;48(1):xv–xvi. Lebwohl B, Green PHR. New developments in celiac disease. Gastroenterol Clin N Am. 2019;48(1):xv–xvi.
18.
Zurück zum Zitat Vilppula A, Kaukinen K, Luostarinen L, Krekela I, Patrikainen H, Valve R, et al. Clinical benefit of gluten-free diet in screen-detected older celiac disease patients. BMC Gastroenterol. 2011;11:136.PubMedPubMedCentral Vilppula A, Kaukinen K, Luostarinen L, Krekela I, Patrikainen H, Valve R, et al. Clinical benefit of gluten-free diet in screen-detected older celiac disease patients. BMC Gastroenterol. 2011;11:136.PubMedPubMedCentral
19.
Zurück zum Zitat Ivarsson A, Myleus A, Norstrom F, van der Pals M, Rosen A, Hogberg L, et al. Prevalence of childhood celiac disease and changes in infant feeding. Pediatrics. 2013;131(3):e687–94.PubMed Ivarsson A, Myleus A, Norstrom F, van der Pals M, Rosen A, Hogberg L, et al. Prevalence of childhood celiac disease and changes in infant feeding. Pediatrics. 2013;131(3):e687–94.PubMed
20.
Zurück zum Zitat Hogberg L, Falth-Magnusson K, Grodzinsky E, Stenhammar L. Familial prevalence of coeliac disease: a twenty-year follow-up study. Scand J Gastroenterol. 2003;38(1):61–5.PubMed Hogberg L, Falth-Magnusson K, Grodzinsky E, Stenhammar L. Familial prevalence of coeliac disease: a twenty-year follow-up study. Scand J Gastroenterol. 2003;38(1):61–5.PubMed
21.
Zurück zum Zitat Caffarelli C, Di Mauro D, Mastrorilli C, Bottau P, Cipriani F, Ricci G. Solid food introduction and the development of food allergies. Nutrients. 2018;10(11).PubMedCentral Caffarelli C, Di Mauro D, Mastrorilli C, Bottau P, Cipriani F, Ricci G. Solid food introduction and the development of food allergies. Nutrients. 2018;10(11).PubMedCentral
22.
Zurück zum Zitat Chmielewska A, Piescik-Lech M, Szajewska H, Shamir R. Primary prevention of celiac disease: environmental factors with a focus on early nutrition. Ann Nutr Metab. 2015;67(Suppl 2):43–50.PubMed Chmielewska A, Piescik-Lech M, Szajewska H, Shamir R. Primary prevention of celiac disease: environmental factors with a focus on early nutrition. Ann Nutr Metab. 2015;67(Suppl 2):43–50.PubMed
23.
Zurück zum Zitat Szajewska H, Shamir R, Mearin L, Ribes-Koninckx C, Catassi C, Domellof M, et al. Gluten introduction and the risk of coeliac disease: a position paper by the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2016;62(3):507–13.PubMed Szajewska H, Shamir R, Mearin L, Ribes-Koninckx C, Catassi C, Domellof M, et al. Gluten introduction and the risk of coeliac disease: a position paper by the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2016;62(3):507–13.PubMed
24.
Zurück zum Zitat •• Lionetti E, Castellaneta S, Francavilla R, Pulvirenti A, Tonutti E, Amarri S, et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med. 2014;371(14):1295–303 COMMENT: Observational prospective study investigating the contribution of environmental factors to celiac disease onset.PubMed •• Lionetti E, Castellaneta S, Francavilla R, Pulvirenti A, Tonutti E, Amarri S, et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med. 2014;371(14):1295–303 COMMENT: Observational prospective study investigating the contribution of environmental factors to celiac disease onset.PubMed
25.
Zurück zum Zitat •• Vriezinga SL, Auricchio R, Bravi E, Castillejo G, Chmielewska A, Crespo Escobar P, et al. Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med. 2014;371(14):1304–15 COMMENT: Observational prospective study investigating the contribution of environmental factors to celiac disease onset.PubMed •• Vriezinga SL, Auricchio R, Bravi E, Castillejo G, Chmielewska A, Crespo Escobar P, et al. Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med. 2014;371(14):1304–15 COMMENT: Observational prospective study investigating the contribution of environmental factors to celiac disease onset.PubMed
26.
Zurück zum Zitat Savvateeva LV, Gorokhovets NV, Makarov VA, Serebryakova MV, Solovyev AG, Morozov SY, et al. Glutenase and collagenase activities of wheat cysteine protease Triticain-alpha: feasibility for enzymatic therapy assays. Int J Biochem Cell Biol. 2015;62:115–24.PubMed Savvateeva LV, Gorokhovets NV, Makarov VA, Serebryakova MV, Solovyev AG, Morozov SY, et al. Glutenase and collagenase activities of wheat cysteine protease Triticain-alpha: feasibility for enzymatic therapy assays. Int J Biochem Cell Biol. 2015;62:115–24.PubMed
27.
Zurück zum Zitat Savvateeva LV, Zamyatnin AA. Prospects of developing medicinal therapeutic strategies and pharmaceutical design for effective gluten intolerance treatment. Curr Pharm Des. 2016;22(16):2439–49.PubMed Savvateeva LV, Zamyatnin AA. Prospects of developing medicinal therapeutic strategies and pharmaceutical design for effective gluten intolerance treatment. Curr Pharm Des. 2016;22(16):2439–49.PubMed
28.
Zurück zum Zitat Tanner GJ, Howitt CA, Forrester RI, Campbell PM, Tye-Din JA, Anderson RP. Dissecting the T-cell response to hordeins in coeliac disease can develop barley with reduced immunotoxicity. Aliment Pharmacol Ther. 2010;32(9):1184–91.PubMed Tanner GJ, Howitt CA, Forrester RI, Campbell PM, Tye-Din JA, Anderson RP. Dissecting the T-cell response to hordeins in coeliac disease can develop barley with reduced immunotoxicity. Aliment Pharmacol Ther. 2010;32(9):1184–91.PubMed
29.
Zurück zum Zitat Altenbach SB, Allen PV. Transformation of the US bread wheat ‘Butte 86’ and silencing of omega-5 gliadin genes. GM Crops. 2011;2(1):66–73.PubMed Altenbach SB, Allen PV. Transformation of the US bread wheat ‘Butte 86’ and silencing of omega-5 gliadin genes. GM Crops. 2011;2(1):66–73.PubMed
30.
Zurück zum Zitat Serena G, Kelly CP, Fasano A. Nondietary therapies for celiac disease. Gastroenterol Clin N Am. 2019;48(1):145–63. Serena G, Kelly CP, Fasano A. Nondietary therapies for celiac disease. Gastroenterol Clin N Am. 2019;48(1):145–63.
31.
Zurück zum Zitat Pisapia L, Camarca A, Picascia S, Bassi V, Barba P, Del Pozzo G, et al. HLA-DQ2.5 genes associated with celiac disease risk are preferentially expressed with respect to non-predisposing HLA genes: implication for anti-gluten T cell response. J Autoimmun. 2016;70:63–72.PubMed Pisapia L, Camarca A, Picascia S, Bassi V, Barba P, Del Pozzo G, et al. HLA-DQ2.5 genes associated with celiac disease risk are preferentially expressed with respect to non-predisposing HLA genes: implication for anti-gluten T cell response. J Autoimmun. 2016;70:63–72.PubMed
32.
Zurück zum Zitat Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med. 1989;169(1):345–50.PubMed Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med. 1989;169(1):345–50.PubMed
33.
Zurück zum Zitat Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology. 1993;105(3):910–22.PubMed Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology. 1993;105(3):910–22.PubMed
34.
Zurück zum Zitat Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet. 2010;42(4):295–302.PubMedPubMedCentral Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet. 2010;42(4):295–302.PubMedPubMedCentral
35.
Zurück zum Zitat Hunt KA, van Heel DA. Recent advances in coeliac disease genetics. Gut. 2009;58(4):473–6.PubMed Hunt KA, van Heel DA. Recent advances in coeliac disease genetics. Gut. 2009;58(4):473–6.PubMed
36.
Zurück zum Zitat Greco L, Romino R, Coto I, Di Cosmo N, Percopo S, Maglio M, et al. The first large population based twin study of coeliac disease. Gut. 2002;50(5):624–8.PubMedPubMedCentral Greco L, Romino R, Coto I, Di Cosmo N, Percopo S, Maglio M, et al. The first large population based twin study of coeliac disease. Gut. 2002;50(5):624–8.PubMedPubMedCentral
37.
Zurück zum Zitat Schirru E, Jores RD, Cicotto L, Frau F, De Virgiliis S, Rossino R, et al. High frequency of low-risk human leukocyte antigen class II genotypes in latent celiac disease. Hum Immunol. 2011;72(2):179–82.PubMed Schirru E, Jores RD, Cicotto L, Frau F, De Virgiliis S, Rossino R, et al. High frequency of low-risk human leukocyte antigen class II genotypes in latent celiac disease. Hum Immunol. 2011;72(2):179–82.PubMed
38.
Zurück zum Zitat Abraham G, Tye-Din JA, Bhalala OG, Kowalczyk A, Zobel J, Inouye M. Accurate and robust genomic prediction of celiac disease using statistical learning. PLoS Genet. 2014;10(2):e1004137.PubMedPubMedCentral Abraham G, Tye-Din JA, Bhalala OG, Kowalczyk A, Zobel J, Inouye M. Accurate and robust genomic prediction of celiac disease using statistical learning. PLoS Genet. 2014;10(2):e1004137.PubMedPubMedCentral
39.
Zurück zum Zitat Leonard MM, Serena G, Sturgeon C, Fasano A. Genetics and celiac disease: the importance of screening. Expert Rev Gastroenterol Hepatol. 2015;9(2):209–15.PubMed Leonard MM, Serena G, Sturgeon C, Fasano A. Genetics and celiac disease: the importance of screening. Expert Rev Gastroenterol Hepatol. 2015;9(2):209–15.PubMed
40.
Zurück zum Zitat Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A. 2009;106(39):16799–804.PubMedPubMedCentral Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A. 2009;106(39):16799–804.PubMedPubMedCentral
41.
Zurück zum Zitat •• Leonard MM, Bai Y, Serena G, Nickerson KP, Camhi S, Sturgeon C, et al. RNA sequencing of intestinal mucosa reveals novel pathways functionally linked to celiac disease pathogenesis. PLoS One. 2019;14(4):e0215132 COMMENT: Study highlighting novel non-HLA genes involved in celiac pathogenesis.PubMedPubMedCentral •• Leonard MM, Bai Y, Serena G, Nickerson KP, Camhi S, Sturgeon C, et al. RNA sequencing of intestinal mucosa reveals novel pathways functionally linked to celiac disease pathogenesis. PLoS One. 2019;14(4):e0215132 COMMENT: Study highlighting novel non-HLA genes involved in celiac pathogenesis.PubMedPubMedCentral
42.
Zurück zum Zitat Catassi C, Gatti S, Fasano A. The new epidemiology of celiac disease. J Pediatr Gastroenterol Nutr. 2014;59(Suppl 1):S7–9.PubMed Catassi C, Gatti S, Fasano A. The new epidemiology of celiac disease. J Pediatr Gastroenterol Nutr. 2014;59(Suppl 1):S7–9.PubMed
43.
Zurück zum Zitat Malamut G, Cellier C. Refractory celiac disease: epidemiology and clinical manifestations. Dig Dis. 2015;33(2):221–6.PubMed Malamut G, Cellier C. Refractory celiac disease: epidemiology and clinical manifestations. Dig Dis. 2015;33(2):221–6.PubMed
44.
Zurück zum Zitat Akobeng AK, Heller RF. Assessing the population impact of low rates of breast feeding on asthma, coeliac disease and obesity: the use of a new statistical method. Arch Dis Child. 2007;92(6):483–5.PubMed Akobeng AK, Heller RF. Assessing the population impact of low rates of breast feeding on asthma, coeliac disease and obesity: the use of a new statistical method. Arch Dis Child. 2007;92(6):483–5.PubMed
45.
Zurück zum Zitat Silano M, Agostoni C, Guandalini S. Effect of the timing of gluten introduction on the development of celiac disease. World J Gastroenterol. 2010;16(16):1939–42.PubMedPubMedCentral Silano M, Agostoni C, Guandalini S. Effect of the timing of gluten introduction on the development of celiac disease. World J Gastroenterol. 2010;16(16):1939–42.PubMedPubMedCentral
46.
Zurück zum Zitat Agostoni C, Shamir R. Can a change in policy of complementary infant feeding reduce the risk for type 1 diabetes and celiac disease? Pediatr Endocrinol Rev. 2008;6(1):2–4.PubMed Agostoni C, Shamir R. Can a change in policy of complementary infant feeding reduce the risk for type 1 diabetes and celiac disease? Pediatr Endocrinol Rev. 2008;6(1):2–4.PubMed
47.
Zurück zum Zitat Troncone R, Ivarsson A, Szajewska H, Mearin ML. Members of European multistakeholder platform on CD. Review article: future research on coeliac disease - a position report from the European multistakeholder platform on coeliac disease (CDEUSSA). Aliment Pharmacol Ther. 2008;27(11):1030–43.PubMed Troncone R, Ivarsson A, Szajewska H, Mearin ML. Members of European multistakeholder platform on CD. Review article: future research on coeliac disease - a position report from the European multistakeholder platform on coeliac disease (CDEUSSA). Aliment Pharmacol Ther. 2008;27(11):1030–43.PubMed
48.
Zurück zum Zitat Bethune MT, Khosla C. Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog. 2008;4(2):e34.PubMedPubMedCentral Bethune MT, Khosla C. Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog. 2008;4(2):e34.PubMedPubMedCentral
49.
Zurück zum Zitat Jabri B, Sollid LM. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol. 2009;9(12):858–70.PubMed Jabri B, Sollid LM. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol. 2009;9(12):858–70.PubMed
50.
Zurück zum Zitat Bach JF. The protective effect of infections on immune disorders. J Pediatr Gastroenterol Nutr. 2005;40(Suppl 1):S8.PubMed Bach JF. The protective effect of infections on immune disorders. J Pediatr Gastroenterol Nutr. 2005;40(Suppl 1):S8.PubMed
51.
Zurück zum Zitat •• Lerner A, Arleevskaya M, Schmiedl A, Matthias T. Microbes and viruses are bugging the gut in celiac disease. Are they friends or foes? Front Microbiol. 2017;8:1392 COMMENT: Comprehensive review summarizing the role of infections in celiac disease pathogenesis.PubMedPubMedCentral •• Lerner A, Arleevskaya M, Schmiedl A, Matthias T. Microbes and viruses are bugging the gut in celiac disease. Are they friends or foes? Front Microbiol. 2017;8:1392 COMMENT: Comprehensive review summarizing the role of infections in celiac disease pathogenesis.PubMedPubMedCentral
52.
Zurück zum Zitat Sandberg-Bennich S, Dahlquist G, Kallen B. Coeliac disease is associated with intrauterine growth and neonatal infections. Acta Paediatr. 2002;91(1):30–3.PubMed Sandberg-Bennich S, Dahlquist G, Kallen B. Coeliac disease is associated with intrauterine growth and neonatal infections. Acta Paediatr. 2002;91(1):30–3.PubMed
53.
Zurück zum Zitat Verdu EF, Galipeau HJ, Jabri B. Novel players in coeliac disease pathogenesis: role of the gut microbiota. Nat Rev Gastroenterol Hepatol. 2015;12(9):497–506.PubMedPubMedCentral Verdu EF, Galipeau HJ, Jabri B. Novel players in coeliac disease pathogenesis: role of the gut microbiota. Nat Rev Gastroenterol Hepatol. 2015;12(9):497–506.PubMedPubMedCentral
54.
Zurück zum Zitat Rostami-Nejad M, Hejazi SH, Pena AS, Asadzadeh-Aghdaei H, Rostami K, Volta U, et al. Contributions of HLA haplotypes, IL8 level and toxoplasma gondii infection in defining celiac disease’s phenotypes. BMC Gastroenterol. 2018;18(1):66.PubMedPubMedCentral Rostami-Nejad M, Hejazi SH, Pena AS, Asadzadeh-Aghdaei H, Rostami K, Volta U, et al. Contributions of HLA haplotypes, IL8 level and toxoplasma gondii infection in defining celiac disease’s phenotypes. BMC Gastroenterol. 2018;18(1):66.PubMedPubMedCentral
55.
Zurück zum Zitat Carroccio A, Cavataio F, Montalto G, Paparo F, Troncone R, Iacono G. Treatment of giardiasis reverses “active” coeliac disease to “latent” coeliac disease. Eur J Gastroenterol Hepatol. 2001;13(9):1101–5.PubMed Carroccio A, Cavataio F, Montalto G, Paparo F, Troncone R, Iacono G. Treatment of giardiasis reverses “active” coeliac disease to “latent” coeliac disease. Eur J Gastroenterol Hepatol. 2001;13(9):1101–5.PubMed
56.
Zurück zum Zitat Pozo-Rubio T, Olivares M, Nova E, De Palma G, Mujico JR, Ferrer MD, et al. Immune development and intestinal microbiota in celiac disease. Clin Dev Immunol. 2012;2012:654143.PubMedPubMedCentral Pozo-Rubio T, Olivares M, Nova E, De Palma G, Mujico JR, Ferrer MD, et al. Immune development and intestinal microbiota in celiac disease. Clin Dev Immunol. 2012;2012:654143.PubMedPubMedCentral
57.
Zurück zum Zitat Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, Emery L, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol. 2006;101(10):2333–40.PubMed Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, Emery L, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol. 2006;101(10):2333–40.PubMed
58.
Zurück zum Zitat Plot L, Amital H, Barzilai O, Ram M, Bizzaro N, Shoenfeld Y. Infections may have a protective role in the etiopathogenesis of celiac disease. Ann N Y Acad Sci. 2009;1173:670–4.PubMed Plot L, Amital H, Barzilai O, Ram M, Bizzaro N, Shoenfeld Y. Infections may have a protective role in the etiopathogenesis of celiac disease. Ann N Y Acad Sci. 2009;1173:670–4.PubMed
59.
Zurück zum Zitat Bartels LE, Jepsen P, Christensen LA, Gerdes LU, Vilstrup H, Dahlerup JF. Diagnosis of helicobacter pylori infection is associated with lower prevalence and subsequent incidence of Crohn’s disease. J Crohns Colitis. 2016;10(4):443–8.PubMed Bartels LE, Jepsen P, Christensen LA, Gerdes LU, Vilstrup H, Dahlerup JF. Diagnosis of helicobacter pylori infection is associated with lower prevalence and subsequent incidence of Crohn’s disease. J Crohns Colitis. 2016;10(4):443–8.PubMed
60.
Zurück zum Zitat Aarup A, Pedersen TX, Junker N, Christoffersen C, Bartels ED, Madsen M, et al. Hypoxia-inducible factor-1alpha expression in macrophages promotes development of atherosclerosis. Arterioscler Thromb Vasc Biol. 2016;36(9):1782–90.PubMed Aarup A, Pedersen TX, Junker N, Christoffersen C, Bartels ED, Madsen M, et al. Hypoxia-inducible factor-1alpha expression in macrophages promotes development of atherosclerosis. Arterioscler Thromb Vasc Biol. 2016;36(9):1782–90.PubMed
61.
Zurück zum Zitat Ruggiero MA, Gordon DP, Orrell TM, Bailly N, Bourgoin T, Brusca RC, et al. A higher level classification of all living organisms. PLoS One. 2015;10(4):e0119248.PubMedPubMedCentral Ruggiero MA, Gordon DP, Orrell TM, Bailly N, Bourgoin T, Brusca RC, et al. A higher level classification of all living organisms. PLoS One. 2015;10(4):e0119248.PubMedPubMedCentral
62.
Zurück zum Zitat Silvester JA, Leffler DA. Is autoimmunity infectious? The effect of gastrointestinal viral infections and vaccination on risk of celiac disease autoimmunity. Clin Gastroenterol Hepatol. 2017;15(5):703–5.PubMed Silvester JA, Leffler DA. Is autoimmunity infectious? The effect of gastrointestinal viral infections and vaccination on risk of celiac disease autoimmunity. Clin Gastroenterol Hepatol. 2017;15(5):703–5.PubMed
63.
Zurück zum Zitat Selmi C. Are helminths to be trusted as allies in the war against autoimmunity and chronic inflammation? Isr Med Assoc J. 2016;18(3–4):139–40.PubMed Selmi C. Are helminths to be trusted as allies in the war against autoimmunity and chronic inflammation? Isr Med Assoc J. 2016;18(3–4):139–40.PubMed
64.
Zurück zum Zitat Lund ME, O’Brien BA, Hutchinson AT, Robinson MW, Simpson AM, Dalton JP, et al. Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouse. PLoS One. 2014;9(1):e86289.PubMedPubMedCentral Lund ME, O’Brien BA, Hutchinson AT, Robinson MW, Simpson AM, Dalton JP, et al. Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouse. PLoS One. 2014;9(1):e86289.PubMedPubMedCentral
65.
Zurück zum Zitat Leonard MM, Weir DC, DeGroote M, Mitchell PD, Singh P, Silvester JA, et al. Value of IgA tTG in predicting mucosal recovery in children with celiac disease on a gluten-free diet. J Pediatr Gastroenterol Nutr. 2017;64(2):286–91.PubMedPubMedCentral Leonard MM, Weir DC, DeGroote M, Mitchell PD, Singh P, Silvester JA, et al. Value of IgA tTG in predicting mucosal recovery in children with celiac disease on a gluten-free diet. J Pediatr Gastroenterol Nutr. 2017;64(2):286–91.PubMedPubMedCentral
66.
Zurück zum Zitat Turroni F, Ribbera A, Foroni E, van Sinderen D, Ventura M. Human gut microbiota and bifidobacteria: from composition to functionality. Antonie Van Leeuwenhoek. 2008;94(1):35–50.PubMed Turroni F, Ribbera A, Foroni E, van Sinderen D, Ventura M. Human gut microbiota and bifidobacteria: from composition to functionality. Antonie Van Leeuwenhoek. 2008;94(1):35–50.PubMed
67.
Zurück zum Zitat Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635–8.PubMedPubMedCentral Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635–8.PubMedPubMedCentral
68.
Zurück zum Zitat Cukrowska B, Sowinska A, Bierla JB, Czarnowska E, Rybak A, Grzybowska-Chlebowczyk U. Intestinal epithelium, intraepithelial lymphocytes and the gut microbiota - key players in the pathogenesis of celiac disease. World J Gastroenterol. 2017;23(42):7505–18.PubMedPubMedCentral Cukrowska B, Sowinska A, Bierla JB, Czarnowska E, Rybak A, Grzybowska-Chlebowczyk U. Intestinal epithelium, intraepithelial lymphocytes and the gut microbiota - key players in the pathogenesis of celiac disease. World J Gastroenterol. 2017;23(42):7505–18.PubMedPubMedCentral
69.
Zurück zum Zitat Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533.PubMedPubMedCentral Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533.PubMedPubMedCentral
70.
Zurück zum Zitat Cukrowska B, Kozakova H, Rehakova Z, Sinkora J, Tlaskalova-Hogenova H. Specific antibody and immunoglobulin responses after intestinal colonization of germ-free piglets with non-pathogenic Escherichia coli O86. Immunobiology. 2001;204(4):425–33.PubMed Cukrowska B, Kozakova H, Rehakova Z, Sinkora J, Tlaskalova-Hogenova H. Specific antibody and immunoglobulin responses after intestinal colonization of germ-free piglets with non-pathogenic Escherichia coli O86. Immunobiology. 2001;204(4):425–33.PubMed
71.
Zurück zum Zitat Tlaskalova-Hogenova H, Stepankova R, Kozakova H, Hudcovic T, Vannucci L, Tuckova L, et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol. 2011;8(2):110–20.PubMedPubMedCentral Tlaskalova-Hogenova H, Stepankova R, Kozakova H, Hudcovic T, Vannucci L, Tuckova L, et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol. 2011;8(2):110–20.PubMedPubMedCentral
72.
Zurück zum Zitat Mikulic J, Longet S, Favre L, Benyacoub J, Corthesy B. Secretory IgA in complex with Lactobacillus rhamnosus potentiates mucosal dendritic cell-mediated Treg cell differentiation via TLR regulatory proteins, RALDH2 and secretion of IL-10 and TGF-beta. Cell Mol Immunol. 2017;14(6):546–56.PubMed Mikulic J, Longet S, Favre L, Benyacoub J, Corthesy B. Secretory IgA in complex with Lactobacillus rhamnosus potentiates mucosal dendritic cell-mediated Treg cell differentiation via TLR regulatory proteins, RALDH2 and secretion of IL-10 and TGF-beta. Cell Mol Immunol. 2017;14(6):546–56.PubMed
73.
Zurück zum Zitat Ismail AS, Behrendt CL, Hooper LV. Reciprocal interactions between commensal bacteria and gamma delta intraepithelial lymphocytes during mucosal injury. J Immunol. 2009;182(5):3047–54.PubMed Ismail AS, Behrendt CL, Hooper LV. Reciprocal interactions between commensal bacteria and gamma delta intraepithelial lymphocytes during mucosal injury. J Immunol. 2009;182(5):3047–54.PubMed
74.
Zurück zum Zitat Sekirov I, Finlay BB. The role of the intestinal microbiota in enteric infection. J Physiol. 2009;587(Pt 17):4159–67.PubMedPubMedCentral Sekirov I, Finlay BB. The role of the intestinal microbiota in enteric infection. J Physiol. 2009;587(Pt 17):4159–67.PubMedPubMedCentral
75.
Zurück zum Zitat Abdellatif AM, Sarvetnick NE. Current understanding of the role of gut dysbiosis in type 1 diabetes. J Diabetes. 2019. Abdellatif AM, Sarvetnick NE. Current understanding of the role of gut dysbiosis in type 1 diabetes. J Diabetes. 2019.
76.
Zurück zum Zitat Castaner O, Goday A, Park YM, Lee SH, Magkos F, Shiow STE, et al. The gut microbiome profile in obesity: a systematic review. Int J Endocrinol. 2018;2018:4095789.PubMedPubMedCentral Castaner O, Goday A, Park YM, Lee SH, Magkos F, Shiow STE, et al. The gut microbiome profile in obesity: a systematic review. Int J Endocrinol. 2018;2018:4095789.PubMedPubMedCentral
77.
Zurück zum Zitat Zuo T, Ng SC. The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease. Front Microbiol. 2018;9:2247.PubMedPubMedCentral Zuo T, Ng SC. The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease. Front Microbiol. 2018;9:2247.PubMedPubMedCentral
78.
Zurück zum Zitat Li Q, Han Y, Dy ABC, Hagerman RJ. The gut microbiota and autism spectrum disorders. Front Cell Neurosci. 2017;11:120.PubMedPubMedCentral Li Q, Han Y, Dy ABC, Hagerman RJ. The gut microbiota and autism spectrum disorders. Front Cell Neurosci. 2017;11:120.PubMedPubMedCentral
79.
Zurück zum Zitat Girbovan A, Sur G, Samasca G, Lupan I. Dysbiosis a risk factor for celiac disease. Med Microbiol Immunol. 2017;206(2):83–91.PubMed Girbovan A, Sur G, Samasca G, Lupan I. Dysbiosis a risk factor for celiac disease. Med Microbiol Immunol. 2017;206(2):83–91.PubMed
80.
Zurück zum Zitat Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol. 2009;62(3):264–9.PubMed Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol. 2009;62(3):264–9.PubMed
81.
Zurück zum Zitat Ou G, Hedberg M, Horstedt P, Baranov V, Forsberg G, Drobni M, et al. Proximal small intestinal microbiota and identification of rod-shaped bacteria associated with childhood celiac disease. Am J Gastroenterol. 2009;104(12):3058–67.PubMed Ou G, Hedberg M, Horstedt P, Baranov V, Forsberg G, Drobni M, et al. Proximal small intestinal microbiota and identification of rod-shaped bacteria associated with childhood celiac disease. Am J Gastroenterol. 2009;104(12):3058–67.PubMed
82.
Zurück zum Zitat De Palma G, Cinova J, Stepankova R, Tuckova L, Sanz Y. Pivotal Advance: Bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease. J Leukoc Biol. 2010;87(5):765–78.PubMed De Palma G, Cinova J, Stepankova R, Tuckova L, Sanz Y. Pivotal Advance: Bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease. J Leukoc Biol. 2010;87(5):765–78.PubMed
83.
Zurück zum Zitat Di Cagno R, De Angelis M, De Pasquale I, Ndagijimana M, Vernocchi P, Ricciuti P, et al. Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol. 2011;11:219.PubMedPubMedCentral Di Cagno R, De Angelis M, De Pasquale I, Ndagijimana M, Vernocchi P, Ricciuti P, et al. Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol. 2011;11:219.PubMedPubMedCentral
84.
Zurück zum Zitat Wacklin P, Kaukinen K, Tuovinen E, Collin P, Lindfors K, Partanen J, et al. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis. 2013;19(5):934–41.PubMed Wacklin P, Kaukinen K, Tuovinen E, Collin P, Lindfors K, Partanen J, et al. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis. 2013;19(5):934–41.PubMed
85.
Zurück zum Zitat Leonard MM, Camhi S, Kenyon V, Betensky RA, Sturgeon C, Yan S, et al. Targeted genotyping for the prediction of celiac disease autoimmunity development in patients with type 1 diabetes and their family members. World J Diabetes. 2019;10(3):189–99.PubMedPubMedCentral Leonard MM, Camhi S, Kenyon V, Betensky RA, Sturgeon C, Yan S, et al. Targeted genotyping for the prediction of celiac disease autoimmunity development in patients with type 1 diabetes and their family members. World J Diabetes. 2019;10(3):189–99.PubMedPubMedCentral
86.
Zurück zum Zitat Sellitto M, Bai G, Serena G, Fricke WF, Sturgeon C, Gajer P, et al. Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One. 2012;7(3):e33387.PubMedPubMedCentral Sellitto M, Bai G, Serena G, Fricke WF, Sturgeon C, Gajer P, et al. Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One. 2012;7(3):e33387.PubMedPubMedCentral
87.
Zurück zum Zitat •• Olivares M, Walker AW, Capilla A, Benitez-Paez A, Palau F, Parkhill J, et al. Gut microbiota trajectory in early life may predict development of celiac disease. Microbiome. 2018;6(1):36 COMMENT: study highlighting changes in microbiome composition prior to development of celiac disease in genetically predisposed infants.PubMedPubMedCentral •• Olivares M, Walker AW, Capilla A, Benitez-Paez A, Palau F, Parkhill J, et al. Gut microbiota trajectory in early life may predict development of celiac disease. Microbiome. 2018;6(1):36 COMMENT: study highlighting changes in microbiome composition prior to development of celiac disease in genetically predisposed infants.PubMedPubMedCentral
88.
Zurück zum Zitat Palma GD, Capilla A, Nova E, Castillejo G, Varea V, Pozo T, et al. Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study. PLoS One. 2012;7(2):e30791.PubMedPubMedCentral Palma GD, Capilla A, Nova E, Castillejo G, Varea V, Pozo T, et al. Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study. PLoS One. 2012;7(2):e30791.PubMedPubMedCentral
89.
Zurück zum Zitat Olivares M, Neef A, Castillejo G, Palma GD, Varea V, Capilla A, et al. The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease. Gut. 2015;64(3):406–17.PubMed Olivares M, Neef A, Castillejo G, Palma GD, Varea V, Capilla A, et al. The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease. Gut. 2015;64(3):406–17.PubMed
90.
Zurück zum Zitat Langdon KJ, Fox AB, King LA, King DW, Eisen S, Vogt D. Examination of the dynamic interplay between posttraumatic stress symptoms and alcohol misuse among combat-exposed Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) Veterans. J Affect Disord. 2016;196:234–42.PubMedPubMedCentral Langdon KJ, Fox AB, King LA, King DW, Eisen S, Vogt D. Examination of the dynamic interplay between posttraumatic stress symptoms and alcohol misuse among combat-exposed Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) Veterans. J Affect Disord. 2016;196:234–42.PubMedPubMedCentral
91.
Zurück zum Zitat Martin VJ, Leonard MM, Fiechtner L, Fasano A. Transitioning from descriptive to mechanistic understanding of the microbiome: the need for a prospective longitudinal approach to predicting disease. J Pediatr. 2016;179:240–8.PubMedPubMedCentral Martin VJ, Leonard MM, Fiechtner L, Fasano A. Transitioning from descriptive to mechanistic understanding of the microbiome: the need for a prospective longitudinal approach to predicting disease. J Pediatr. 2016;179:240–8.PubMedPubMedCentral
92.
Zurück zum Zitat Serena G, Yan S, Camhi S, Patel S, Lima RS, Sapone A, et al. Proinflammatory cytokine interferon-gamma and microbiome-derived metabolites dictate epigenetic switch between forkhead box protein 3 isoforms in coeliac disease. Clin Exp Immunol. 2017;187(3):490–506.PubMedPubMedCentral Serena G, Yan S, Camhi S, Patel S, Lima RS, Sapone A, et al. Proinflammatory cytokine interferon-gamma and microbiome-derived metabolites dictate epigenetic switch between forkhead box protein 3 isoforms in coeliac disease. Clin Exp Immunol. 2017;187(3):490–506.PubMedPubMedCentral
93.
Zurück zum Zitat Freire R, Ingano L, Serena G, Cetinbas M, Anselmo A, Sapone A, et al. Human gut derived-organoids provide model to study gluten response and effects of microbiota-derived molecules in celiac disease. Sci Rep. 2019;9(1):7029.PubMedPubMedCentral Freire R, Ingano L, Serena G, Cetinbas M, Anselmo A, Sapone A, et al. Human gut derived-organoids provide model to study gluten response and effects of microbiota-derived molecules in celiac disease. Sci Rep. 2019;9(1):7029.PubMedPubMedCentral
94.
Zurück zum Zitat Caminero A, McCarville JL, Galipeau HJ, Deraison C, Bernier SP, Constante M, et al. Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2. Nat Commun. 2019;10(1):1198.PubMedPubMedCentral Caminero A, McCarville JL, Galipeau HJ, Deraison C, Bernier SP, Constante M, et al. Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2. Nat Commun. 2019;10(1):1198.PubMedPubMedCentral
95.
Zurück zum Zitat Caminero A, McCarville JL, Zevallos VF, Pigrau M, Yu XB, Jury J, et al. Lactobacilli degrade wheat amylase trypsin inhibitors to reduce intestinal dysfunction induced by immunogenic wheat proteins. Gastroenterology. 2019. Caminero A, McCarville JL, Zevallos VF, Pigrau M, Yu XB, Jury J, et al. Lactobacilli degrade wheat amylase trypsin inhibitors to reduce intestinal dysfunction induced by immunogenic wheat proteins. Gastroenterology. 2019.
96.
Zurück zum Zitat Francavilla R, De Angelis M, Rizzello CG, Cavallo N, Dal Bello F, Gobbetti M. Selected probiotic lactobacilli have the capacity to hydrolyze gluten peptides during simulated gastrointestinal digestion. Appl Environ Microbiol. 2017;83(14). Francavilla R, De Angelis M, Rizzello CG, Cavallo N, Dal Bello F, Gobbetti M. Selected probiotic lactobacilli have the capacity to hydrolyze gluten peptides during simulated gastrointestinal digestion. Appl Environ Microbiol. 2017;83(14).
97.
Zurück zum Zitat Francavilla R, Ercolini D, Piccolo M, Vannini L, Siragusa S, De Filippis F, et al. Salivary microbiota and metabolome associated with celiac disease. Appl Environ Microbiol. 2014;80(11):3416–25.PubMedPubMedCentral Francavilla R, Ercolini D, Piccolo M, Vannini L, Siragusa S, De Filippis F, et al. Salivary microbiota and metabolome associated with celiac disease. Appl Environ Microbiol. 2014;80(11):3416–25.PubMedPubMedCentral
98.
Zurück zum Zitat Serena G. Analysis of blood and fecal microbiome profile in patients with celiac disease. Human Microb J. 2019;11. Serena G. Analysis of blood and fecal microbiome profile in patients with celiac disease. Human Microb J. 2019;11.
99.
Zurück zum Zitat Traykova D, Schneider B, Chojkier M, Buck M. Blood microbiome quantity and the hyperdynamic circulation in decompensated cirrhotic patients. PLoS One. 2017;12(2):e0169310.PubMedPubMedCentral Traykova D, Schneider B, Chojkier M, Buck M. Blood microbiome quantity and the hyperdynamic circulation in decompensated cirrhotic patients. PLoS One. 2017;12(2):e0169310.PubMedPubMedCentral
100.
Zurück zum Zitat De Angelis M, Rizzello CG, Fasano A, Clemente MG, De Simone C, Silano M, et al. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for celiac sprue. Biochim Biophys Acta. 2006;1762(1):80–93.PubMed De Angelis M, Rizzello CG, Fasano A, Clemente MG, De Simone C, Silano M, et al. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for celiac sprue. Biochim Biophys Acta. 2006;1762(1):80–93.PubMed
101.
Zurück zum Zitat Primec M, Micetic-Turk D, Langerholc T. Analysis of short-chain fatty acids in human feces: a scoping review. Anal Biochem. 2017;526:9–21.PubMed Primec M, Micetic-Turk D, Langerholc T. Analysis of short-chain fatty acids in human feces: a scoping review. Anal Biochem. 2017;526:9–21.PubMed
Metadaten
Titel
Genetic and Environmental Contributors for Celiac Disease
verfasst von
Gloria Serena
Rosiane Lima
Alessio Fasano
Publikationsdatum
01.09.2019
Verlag
Springer US
Erschienen in
Current Allergy and Asthma Reports / Ausgabe 9/2019
Print ISSN: 1529-7322
Elektronische ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-019-0871-5

Weitere Artikel der Ausgabe 9/2019

Current Allergy and Asthma Reports 9/2019 Zur Ausgabe

Pediatric Allergy and Immunology (W Dolen, Section Editor)

Drug Safety Evaluation in China

Allergies and the Environment (M Hernandez, Section Editor)

Environmental Exposures and Asthma in Active Duty Service Members

Autoimmunity (TK Tarrant, Section Editor)

Update on the Genetics of Autoinflammatory Disorders

Allergic Skin Diseases (L Fonacier and A Wollenberg Section Editors)

Occupational Dermatosis

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

HNO-Op. auch mit über 90?

16.04.2024 HNO-Chirurgie Nachrichten

Mit Blick auf das Risiko für Komplikationen nach elektiven Eingriffen im HNO-Bereich scheint das Alter der Patienten kein ausschlaggebender Faktor zu sein. Entscheidend ist offenbar, wie fit die Betroffenen tatsächlich sind.

Intrakapsuläre Tonsillektomie gewinnt an Boden

16.04.2024 Tonsillektomie Nachrichten

Gegenüber der vollständigen Entfernung der Gaumenmandeln hat die intrakapsuläre Tonsillektomie einige Vorteile, wie HNO-Fachleute aus den USA hervorheben. Sie haben die aktuelle Literatur zu dem Verfahren gesichtet.

Bilateraler Hörsturz hat eine schlechte Prognose

15.04.2024 Hörsturz Nachrichten

Die Mehrzahl der Menschen mit Hörsturz ist einseitig betroffen, doch auch ein beidseitiger Hörsturz ist möglich. Wie häufig solche Fälle sind und wie sich ihr Verlauf darstellt, hat eine HNO-Expertenrunde aus den USA untersucht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.